BRISTOL-MYERS SQUIBB COMPANY Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of 2.70% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2026-02-11
- BRISTOL-MYERS SQUIBB COMPANY effective income tax rate reconciliation, other adjustments, percent for the quarter ending 2019-09-30 was 13.10%, a 773.33% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY effective income tax rate reconciliation, other adjustments, percent for the quarter ending 2019-06-30 was 0.50%, a 94.19% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY effective income tax rate reconciliation, other adjustments, percent for the quarter ending 2019-03-31 was 1.20%, a 0.00% change year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY effective income tax rate reconciliation, other adjustments, percent for the quarter ending 2018-09-30 was 1.50%, a 68.09% decline year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY effective income tax rate reconciliation, other adjustments, percent for fiscal 2025 was 2.70%.
- BRISTOL-MYERS SQUIBB COMPANY effective income tax rate reconciliation, other adjustments, percent for fiscal 2022 was 8.20%, a 2.50% increase from fiscal 2021.
- BRISTOL-MYERS SQUIBB COMPANY effective income tax rate reconciliation, other adjustments, percent for fiscal 2021 was 8.00%.
- BRISTOL-MYERS SQUIBB COMPANY effective income tax rate reconciliation, other adjustments, percent for fiscal 2020 was -10.00%, a 158.48% decline from fiscal 2019.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 3 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 3 month as first filed | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 6 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 6 month as first filed | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 9 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | 2.70% 10-K · filed 2026-02-11 | ||||||
| 2022-12-31 | 8.20% 10-K · filed 2023-02-14 | ||||||
| 2021-12-31 | 8.00% 10-K · filed 2023-02-14 | 8.50% 10-K · filed 2022-02-09 | |||||
| 2020-12-31 | -10.00% 10-K · filed 2023-02-14 | -10.60% 10-K · filed 2021-02-10 | |||||
| 2020-09-30 | 31.30% 10-Q · filed 2020-11-05 | ||||||
| 2019-12-31 | 17.10% 10-K · filed 2022-02-09 | ||||||
| 2019-09-30 | 13.10% 10-Q · filed 2019-10-31 | 3.60% 10-Q · filed 2019-10-31 | |||||
| 2019-06-30 | 0.50% 10-Q · filed 2019-07-25 | 0.60% 10-Q · filed 2019-07-25 | |||||
| 2019-03-31 | 1.20% 10-Q · filed 2019-04-25 | ||||||
| 2018-12-31 | 1.60% 10-K · filed 2021-02-10 | ||||||
| 2018-09-30 | 1.50% 10-Q · filed 2019-10-31 | 0.80% 10-Q · filed 2019-10-31 | |||||
| 2018-06-30 | 8.60% 10-Q · filed 2019-07-25 | 0.00% 10-Q · filed 2018-07-26 | 0.90% 10-Q · filed 2019-07-25 | ||||
| 2018-03-31 | 1.20% 10-Q · filed 2019-04-25 | ||||||
| 2017-12-31 | 0.00% 10-K · filed 2020-02-24 | -1.90% 10-K · filed 2018-02-13 | |||||
| 2017-09-30 | 4.70% 10-Q · filed 2018-10-25 | 3.70% 10-Q · filed 2018-10-25 | |||||
| 2017-06-30 | 0.00% 10-Q · filed 2018-07-26 | 0.00% 10-Q · filed 2018-07-26 | 3.50% 10-Q · filed 2017-07-27 | ||||
| 2017-03-31 | 1.70% 10-Q · filed 2018-04-26 | ||||||
| 2016-12-31 | 0.00% 10-K · filed 2019-02-25 | -1.60% 10-K · filed 2017-02-21 | |||||
| 2016-09-30 | 3.10% 10-Q · filed 2017-10-26 | ||||||
| 2016-06-30 | 4.00% 10-Q · filed 2017-07-27 | ||||||
| 2016-03-31 | 4.40% 10-Q · filed 2017-04-27 | ||||||
| 2015-12-31 | 1.60% 10-K · filed 2018-02-13 | -1.90% 10-K · filed 2016-02-12 | |||||
| 2014-12-31 | -1.90% 10-K · filed 2017-02-21 | -3.10% 10-K · filed 2015-02-13 | |||||
| 2013-12-31 | -2.60% 10-K · filed 2016-02-12 | -4.20% 10-K · filed 2014-02-14 | |||||
| 2012-12-31 | -1.90% 10-K · filed 2015-02-13 | -3.30% 10-K · filed 2013-02-15 | |||||
| 2011-12-31 | -0.20% 10-K · filed 2014-02-14 | ||||||
| 2010-12-31 | 1.10% 10-K · filed 2013-02-15 | ||||||
| 2009-12-31 | -1.00% 10-K · filed 2012-02-17 | ||||||
| 2008-12-31 | 1.40% 10-K · filed 2011-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |